1
|
In FUS[1−359]‐tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome. Biomed Pharmacother 2022; 156:113986. [DOI: 10.1016/j.biopha.2022.113986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2022] [Revised: 10/25/2022] [Accepted: 11/04/2022] [Indexed: 11/09/2022] Open
|
2
|
Soldatov VO, Kukharsky MS, Soldatova MO, Puchenkova OA, Nikitina Y, Lysikova EA, Kartashkina NL, Deykin AV, Pokrovskiy MV. Retinal abnormalities in transgenic mice overexpressing aberrant human FUS[1-359] gene. BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY 2021. [DOI: 10.24075/brsmu.2021.043] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Retinal damage is an optional sign in a number of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). The aim of this work was to assess the structural and functional state of the retina in a murine model of ALS caused by overexpression of the aberrant FUS protein [1-359]. The retinal examination was carried out on 12 transgenic and 13 wild-type mice of 2.5–3 months of age. The study revealed not statistically significant higher level of ophthalmoscopic violations in FUS[1-359] mice. Moreover, gene expression assay confirmed an increased expression of the inflammatory genes Vegfa, Il1b, Il6, Icam1, Tnfa. However, despite the detected structural and functional abnormalities, western blot analysis and quantitative PCR did not detect the expression of the protein and mRNA products of the FUS transgene in the retina of FUS[1-359] mice.
Collapse
Affiliation(s)
- VO Soldatov
- Belgorod State National Research University, Belgorod, Russia
| | - MS Kukharsky
- Institute of Physiologically Active Substances, Moscow, Russia
| | | | - OA Puchenkova
- Belgorod State National Research University, Belgorod, Russia
| | - YuA Nikitina
- Institute of Physiologically Active Substances, Moscow, Russia
| | - EA Lysikova
- Institute of Physiologically Active Substances, Moscow, Russia
| | - NL Kartashkina
- Sechenov First Moscow State Medical University, Moscow, Russia
| | - AV Deykin
- Belgorod State National Research University, Belgorod, Russia
| | - MV Pokrovskiy
- Belgorod State National Research University, Belgorod, Russia
| |
Collapse
|